Back to Home
Podcast

The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis

Release Date

August 29, 2022

Expiration Date

August 30, 2023

Credits

0.5 On-Demand

Topics

Hematology, Oncology+1 more

Program Description

Costs of care for patients with myelofibrosis are reported to range from 2 to 6 times higher than for individuals without cancer. Managed care pharmacists can support care coordination and operations to reduce the financial burden for patients with myelofibrosis and its impact on quality of life. The discussion in this third podcast in the series will center on best practices and recommendations for the multidisciplinary management of patients with myelofibrosis.


Target audience: Managed care and oncology pharmacists

Type of activity: Knowledge
Release date: August 29, 2022
Expiration date: August 29, 2023

Time to complete activity: 0.5 hour
Fee: Free

Educational Objective

At the completion of this activity, participants will be able to:

  • Recognize the quality-of-life impacts and cost of therapy challenges patients with myelofibrosis face and explore strategies available to better manage this diagnosis
The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here
What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Follow Us on Social Media!

Course

The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis

Create Account